Discover how transitioning to iPSC-based allogeneic cell therapies can revolutionize modern healthcare
Join Jonas Mortensen, Cellistic's Chief Commercial Officer, as he leads a discussion on the rapidly advancing field of cell therapy.
In this insightful webinar, you'll also hear from our experts:
- Suzanne Snellenberg, VP of Cell Line Development
- Anne-Sophie Lebrun, MSAT Director
They’ll take you step-by-step through the product journey, featuring:
- Pulse Platform: Tailored for developing your iPSC cell line
- Echo Platform: Designed for differentiating into functional NK cells
Discover how these platforms integrate to power your cell therapy development from start to finish.
Click below to watch the webinar replay and don’t hesitate to contact us via the form below if you want to learn more about iPSCs and Cellistic's unique approach.